With longevity in focus, Arbonne unveiled a two-part NAD+ system that pairs the Arbonne Intelligence NAD+ Cellular Energy dietary supplement with a clinically tested topical Arbonne Intelligence NAD+ Cellular Skin Booster treatment. Together, these products deliver comprehensive NAD+ support, fueling energy and resilience from the inside out, while visibly transforming the appearance of skin from the outside in. "NAD+ is foundational cellular fuel," said Anne Silsby, Chief Marketing Officer. "Our new duo makes healthy aging achievable every day."
While the once-daily Arbonne Intelligence NAD+ Cellular Energy stick pack is powered by Niagen and other key ingredients like selenium, ginkgo biloba leaf extract and Vitamin B12, the lightweight Arbonne Intelligence NAD+ Cellular Skin Booster eye and face serum boasts visibly firming, smoothing and revitalizing benefits.
What Makes This Trend Stand Out
- Integrated Oral-topical Longevity Regimens
- Combining ingestible NAD+ supplements with topical boosters creates multi-modal protocols that could redefine efficacy expectations for anti-aging products.
- NAD+ Bioactive Mainstreaming
- Mainstream incorporation of Niagen and NAD+-supporting actives signals a shift toward bioactive ingredients becoming central selling points rather than niche claims.
- Personalized Cellular-fueling Supplements
- Customized dosing and ingredient stacks tailored to individual metabolic and cellular profiles open possibilities for highly targeted longevity supplementation.
Sectors Adopting This
- Skincare and Dermatology
- Clinically validated topical NAD+ treatments present opportunities to merge cosmetic outcomes with measurable cellular biomarkers in dermatology care.
- Nutraceuticals and Supplements
- Formulations featuring Niagen alongside synergistic botanicals and micronutrients could shift the supplement market toward clinically substantiated cellular resilience products.
- Wellness Tech and Diagnostics
- At-home diagnostics and monitoring tools that track NAD+ status and cellular health could enable personalized regimen recommendations and efficacy validation.
